Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Thera
(NQ:
VKTX
)
52.94
-1.57 (-2.88%)
Streaming Delayed Price
Updated: 1:00 PM EST, Nov 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Thera
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
July 17, 2024
Roche released early-stage data on its oral weight-loss drug.
Via
Investor's Business Daily
Is Viking Therapeutics the Best Biotech Stock for You?
July 17, 2024
Let's look beyond the hype the company is generating this year.
Via
The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy in July 2024
July 12, 2024
There’s always a strong case for undervalued biotech stocks especially with newer innovation and demand for better treatment.
Via
InvestorPlace
Is Viking Therapeutics Stock Running Out of Steam?
July 11, 2024
Viking's stock has tripled in less than a year, and its red-hot valuation could have investors thinking twice about buying it today.
Via
The Motley Fool
Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics
July 10, 2024
Both competitors have promising lead programs, and enough cash, too.
Via
The Motley Fool
Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug
July 09, 2024
Global pharmaceutical company Eli Lilly & Co. (NYSE: LLY) has been in a GLP-1 arms race with its FDA-approved therapies Mounjaro and Zepbound. It's been
Via
MarketBeat
Spotlight on Viking Therapeutics: Analyzing the Surge in Options Activity
July 05, 2024
Via
Benzinga
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
July 01, 2024
Via
Benzinga
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
July 09, 2024
This pharma company is posting double-digit revenue growth.
Via
The Motley Fool
3 Overlooked Giants-in-the-Making for Patient Investors
July 08, 2024
Consider buying into these overlooked growth stocks for long-term profits that will help to boost a portfolio and deliver riches.
Via
InvestorPlace
The 7 Best Under $10 Stocks to Buy in July 2024
July 06, 2024
We’re finding big opportunities in some of the best stocks under $10 a share. In fact, here are seven you may want to jump into now.
Via
InvestorPlace
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
July 04, 2024
Eli Lilly is a good stock to buy, but these should be even better.
Via
The Motley Fool
Viking Therapeutics Unusual Options Activity For June 25
June 25, 2024
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $600 Today
June 18, 2024
Via
Benzinga
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
July 03, 2024
The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for rate cuts following June’s sharply lower-than-expected services sector...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
3 Biotech Moonshots With Imminent Catalyst Potential
July 03, 2024
Biotech has been one of the most explosive sectors. Better, further upside is likely, thanks to some of the top biotech stocks with catalysts.
Via
InvestorPlace
Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
July 03, 2024
Clinical-state biopharmaceutical company Altimmune Inc. (NASDAQ: ALT) focuses on developing peptide-based therapeutics for obesity and chronic liver diseases
Via
MarketBeat
Exposures
Product Safety
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
July 02, 2024
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) has been trying to enter the weight-loss treatment trend dominated by GLP-1 drug makers like Ozempic and Wegovy
Via
MarketBeat
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
July 01, 2024
Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound.
Via
MarketBeat
Exposures
Product Safety
Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?
July 01, 2024
It's a tough act to follow.
Via
The Motley Fool
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
June 30, 2024
While their share prices have traveled different paths recently, the similarity between the two companies is striking.
Via
The Motley Fool
The 3 Smartest Biotech Stocks to Buy With $5K Right Now
June 28, 2024
With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs.
Via
InvestorPlace
The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains
June 28, 2024
Consider buying shares in these pharma companies, each of which is a leader in the weight loss drug sector.
Via
InvestorPlace
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
June 28, 2024
These healthcare stocks have clear paths to growth over the next few years.
Via
The Motley Fool
Better Growth Stock: Archer Aviation or Viking Therapeutics?
June 26, 2024
Which one of these potential disruptors is the better buy?
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
June 25, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 24, 2024
Via
Benzinga
The Best Biotech Stock to Invest $1,000 in Right Now
June 18, 2024
This stock may not be a slam dunk, but it's looking very promising.
Via
The Motley Fool
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
June 17, 2024
These high-flying stocks could have more room to run if analysts are right.
Via
The Motley Fool
2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%
June 15, 2024
There's a lot of hope for these stocks, but there's also a fair amount of risk.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.